| Survival (mean ± SD, n = 39) | Late death (mean ± SD, n = 11) | p |
---|---|---|---|
APACHI II | 14.8 ± 1.33 | 22.4 ± 3.19 | 0.000 |
Best GCS > = 8 (Y/N) | 37/2 | 6/5 | 0.004 |
Inotropic agent use (Y/N) | 7/32 | 11/0 | 0.000 |
Best PaO2 (mmHg) | 68.8 ± 6.77 | 76.4 ± 9.33 | n.s. |
Lowest FiO2 (%) | 240 ± 42.5 | 251 ± 112 | n.s. |
WBC (103/dl) | 13.3k ± 5.66k | 7.29k ± 5.57k | 0.020 |
Hb (g/dl) | 11.4 ± 0.32 | 11.0 ± 1.63 | n.s. |
PLT (103/dl) | 88.6k ± 17.7k | 94.4k ± 36.8k | n.s. |
INR | 1.47 ± 0.89 | 1.81 ± 0.33 | 0.016 |
Na (meq/l) | 143 ± 7.41 | 151 ± 2.89 | n.s. |
K (meq/l) | 3.76 ± 0.29 | 3.83 ± 0.53 | n.s. |
Cr (mg/dl) | 1.27 ± 0.44 | 1.10 ± 0.27 | n.s. |
Total bilirubin (mg/dl) | 1.44 ± 0.46 | 1.27 ± 0.47 | n.s. |
Hemodialysis (Y/N) | 2/37 | 4/7 | 0.017 |
ECMO use (Y/N) | 0/39 | 2/9 | 0.045 |
DCL wound open care (Y/N) | 21/18 | 7/4 | n.s. |
Duration of laparotomy wound opened (days) | 2.03 ± 2.91 | 1.11 ± 1.70 | n.s |
Accumulated blood Transfusion (U) | 19.6 ± 4.16 | 32.9 ± 10.9 | 0.014 |